Rodrigo Wagner Alves De Souza, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Physical Conditioning, Animal | 7 | 2021 | 365 | 1.410 |
Why?
|
Muscular Atrophy | 6 | 2021 | 334 | 1.060 |
Why?
|
Carbon Monoxide | 3 | 2024 | 547 | 1.060 |
Why?
|
Muscle, Skeletal | 12 | 2021 | 4948 | 1.030 |
Why?
|
Walking | 3 | 2021 | 1198 | 1.020 |
Why?
|
Heme Oxygenase-1 | 3 | 2024 | 366 | 0.870 |
Why?
|
Resistance Training | 4 | 2019 | 193 | 0.850 |
Why?
|
Heme | 2 | 2021 | 313 | 0.810 |
Why?
|
Muscle Fibers, Skeletal | 4 | 2021 | 542 | 0.800 |
Why?
|
Doxorubicin | 2 | 2024 | 2224 | 0.720 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2024 | 678 | 0.700 |
Why?
|
MyoD Protein | 5 | 2021 | 142 | 0.690 |
Why?
|
Intermittent Claudication | 2 | 2021 | 304 | 0.670 |
Why?
|
Nitric Oxide Synthase Type I | 1 | 2017 | 174 | 0.560 |
Why?
|
Membrane Proteins | 2 | 2024 | 7858 | 0.510 |
Why?
|
Rats, Wistar | 12 | 2019 | 1848 | 0.510 |
Why?
|
Oxidative Stress | 3 | 2021 | 3113 | 0.500 |
Why?
|
Physical Exertion | 2 | 2014 | 667 | 0.480 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2017 | 705 | 0.460 |
Why?
|
Peripheral Arterial Disease | 2 | 2021 | 1273 | 0.430 |
Why?
|
Regeneration | 2 | 2017 | 1512 | 0.400 |
Why?
|
Myogenin | 3 | 2016 | 55 | 0.360 |
Why?
|
Exercise | 2 | 2021 | 5890 | 0.310 |
Why?
|
Muscle Proteins | 5 | 2021 | 1154 | 0.310 |
Why?
|
Hypertrophy | 2 | 2019 | 561 | 0.300 |
Why?
|
Cachexia | 1 | 2017 | 202 | 0.260 |
Why?
|
SKP Cullin F-Box Protein Ligases | 4 | 2015 | 175 | 0.250 |
Why?
|
Exercise Test | 3 | 2021 | 2127 | 0.250 |
Why?
|
Inflammation | 2 | 2021 | 10773 | 0.230 |
Why?
|
Carboxyhemoglobin | 1 | 2024 | 83 | 0.230 |
Why?
|
Muscular Diseases | 2 | 2016 | 553 | 0.220 |
Why?
|
Heart Failure | 6 | 2017 | 11670 | 0.210 |
Why?
|
Prodrugs | 1 | 2024 | 261 | 0.210 |
Why?
|
PAX7 Transcription Factor | 1 | 2021 | 55 | 0.190 |
Why?
|
Stress, Physiological | 1 | 2019 | 1403 | 0.190 |
Why?
|
Ferrochelatase | 1 | 2021 | 47 | 0.190 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2021 | 64 | 0.180 |
Why?
|
Adaptation, Physiological | 3 | 2021 | 1301 | 0.180 |
Why?
|
MicroRNAs | 2 | 2017 | 3816 | 0.180 |
Why?
|
Nandrolone | 1 | 2010 | 17 | 0.170 |
Why?
|
Crotalid Venoms | 1 | 2010 | 28 | 0.170 |
Why?
|
Ubiquitin-Protein Ligases | 4 | 2021 | 1899 | 0.170 |
Why?
|
Snake Bites | 1 | 2010 | 28 | 0.170 |
Why?
|
Rats | 11 | 2019 | 23741 | 0.160 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2021 | 691 | 0.160 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 594 | 0.150 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 11904 | 0.150 |
Why?
|
Animals | 20 | 2024 | 168467 | 0.150 |
Why?
|
Ventricular Remodeling | 1 | 2015 | 1267 | 0.150 |
Why?
|
Nitrites | 1 | 2017 | 159 | 0.140 |
Why?
|
Hindlimb Suspension | 1 | 2017 | 75 | 0.140 |
Why?
|
Anabolic Agents | 1 | 2010 | 256 | 0.140 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2017 | 260 | 0.140 |
Why?
|
Rest | 2 | 2019 | 918 | 0.140 |
Why?
|
Isoenzymes | 1 | 2021 | 1687 | 0.130 |
Why?
|
Myocardium | 2 | 2018 | 4725 | 0.130 |
Why?
|
Muscle Fibers, Slow-Twitch | 2 | 2013 | 52 | 0.130 |
Why?
|
Mice, Inbred C57BL | 3 | 2024 | 22172 | 0.130 |
Why?
|
Administration, Oral | 1 | 2024 | 4021 | 0.130 |
Why?
|
Nitrates | 1 | 2017 | 263 | 0.130 |
Why?
|
Muscle Fibers, Fast-Twitch | 2 | 2013 | 70 | 0.130 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2014 | 1935 | 0.130 |
Why?
|
Muscles | 1 | 2010 | 1576 | 0.120 |
Why?
|
Sarcomeres | 1 | 2017 | 368 | 0.120 |
Why?
|
Cysteine | 1 | 2018 | 891 | 0.110 |
Why?
|
Cardiomegaly | 1 | 2016 | 590 | 0.110 |
Why?
|
RNA, Messenger | 2 | 2017 | 12794 | 0.110 |
Why?
|
Bacterial Infections | 1 | 2021 | 1391 | 0.110 |
Why?
|
Myosin Heavy Chains | 2 | 2013 | 405 | 0.110 |
Why?
|
Oxygen | 1 | 2024 | 4227 | 0.100 |
Why?
|
Cardiomyopathies | 1 | 2024 | 1964 | 0.100 |
Why?
|
Calcineurin | 1 | 2013 | 229 | 0.100 |
Why?
|
Nitric Oxide | 1 | 2021 | 2135 | 0.100 |
Why?
|
Swimming | 1 | 2013 | 208 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18253 | 0.090 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9420 | 0.090 |
Why?
|
Imidazoles | 1 | 2017 | 1180 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3879 | 0.090 |
Why?
|
Heart Diseases | 1 | 2024 | 2781 | 0.090 |
Why?
|
NFATC Transcription Factors | 1 | 2013 | 389 | 0.090 |
Why?
|
Mice | 5 | 2024 | 81533 | 0.090 |
Why?
|
Hemorrhage | 1 | 2021 | 3424 | 0.080 |
Why?
|
Atrophy | 1 | 2014 | 1633 | 0.080 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3826 | 0.080 |
Why?
|
Male | 17 | 2024 | 360842 | 0.080 |
Why?
|
Wounds and Injuries | 1 | 2021 | 2491 | 0.080 |
Why?
|
Random Allocation | 2 | 2019 | 2395 | 0.080 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2017 | 2057 | 0.080 |
Why?
|
Mitochondria | 1 | 2021 | 3624 | 0.070 |
Why?
|
Energy Metabolism | 1 | 2018 | 2882 | 0.070 |
Why?
|
Recovery of Function | 2 | 2015 | 2979 | 0.070 |
Why?
|
Body Weight | 1 | 2017 | 4618 | 0.070 |
Why?
|
Histocytochemistry | 1 | 2017 | 698 | 0.070 |
Why?
|
Mice, Knockout | 1 | 2021 | 14416 | 0.060 |
Why?
|
Biometry | 1 | 2017 | 563 | 0.060 |
Why?
|
Physical Endurance | 2 | 2018 | 366 | 0.060 |
Why?
|
Signal Transduction | 2 | 2021 | 23447 | 0.050 |
Why?
|
Morphogenesis | 1 | 2015 | 741 | 0.050 |
Why?
|
Oxidation-Reduction | 2 | 2018 | 2231 | 0.050 |
Why?
|
Bothrops | 1 | 2010 | 9 | 0.040 |
Why?
|
Malate Dehydrogenase | 1 | 2018 | 40 | 0.040 |
Why?
|
Transcription Factors | 2 | 2015 | 12129 | 0.040 |
Why?
|
Cell Respiration | 1 | 2018 | 201 | 0.040 |
Why?
|
Humans | 7 | 2024 | 761572 | 0.040 |
Why?
|
Forkhead Transcription Factors | 2 | 2015 | 1616 | 0.040 |
Why?
|
Mice, Inbred Strains | 1 | 2010 | 1762 | 0.040 |
Why?
|
Myocytes, Cardiac | 1 | 2024 | 1668 | 0.030 |
Why?
|
Necrosis | 1 | 2010 | 1611 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 4575 | 0.030 |
Why?
|
Immobilization | 1 | 2015 | 229 | 0.030 |
Why?
|
Running | 1 | 2018 | 488 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2018 | 836 | 0.030 |
Why?
|
Aortic Valve Stenosis | 1 | 2015 | 2001 | 0.030 |
Why?
|
Nerve Tissue Proteins | 2 | 2015 | 4415 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 1974 | 0.020 |
Why?
|
Monocrotaline | 1 | 2010 | 26 | 0.020 |
Why?
|
Cytokines | 1 | 2015 | 7396 | 0.020 |
Why?
|
Middle Aged | 2 | 2021 | 220920 | 0.020 |
Why?
|
Heart Rate | 1 | 2021 | 4195 | 0.020 |
Why?
|
Models, Biological | 1 | 2016 | 9469 | 0.020 |
Why?
|
Apoptosis | 1 | 2015 | 9489 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 1741 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1699 | 0.020 |
Why?
|
Female | 2 | 2024 | 392686 | 0.020 |
Why?
|
Adenosine Triphosphatases | 1 | 2011 | 836 | 0.020 |
Why?
|
Staining and Labeling | 1 | 2011 | 1085 | 0.020 |
Why?
|
NF-kappa B | 1 | 2014 | 2490 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8481 | 0.020 |
Why?
|
Organ Specificity | 1 | 2010 | 1968 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2021 | 22176 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2014 | 4352 | 0.010 |
Why?
|
Weight Gain | 1 | 2011 | 2348 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18398 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59255 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88324 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 39970 | 0.010 |
Why?
|
Aged | 1 | 2021 | 169310 | 0.000 |
Why?
|
Adult | 1 | 2021 | 221203 | 0.000 |
Why?
|